🔴 Cue Biopharma is trading 5.8% down in after-hours trading with no clear company-specific catalyst identified

Cue Biopharma is trading 5.81% down at $28.26 after no clear company-specific catalyst emerged in available September 8, 2026 coverage.

• Latest identified announcements involve its August 3 CFO appointment and CUE-221 regulatory update, rather than a new after-hours event.
• Broader markets were mixed: the S&P 500 and Dow lower, Nasdaq higher, so market direction does not clearly explain the decline.
• Recheck later for delayed filings or announcements.